Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 May 1;80(5):506-515.
doi: 10.1001/jamaneurol.2023.0218.

Association Between Magnitude of Differential Blood Pressure Reduction and Secondary Stroke Prevention: A Meta-analysis and Meta-Regression

Chia-Yu Hsu  1 , Jeffrey L Saver  2 , Bruce Ovbiagele  3 , Yi-Ling Wu  4 , Chun-Yu Cheng  5 , Meng Lee  1
Affiliations
Meta-Analysis

Association Between Magnitude of Differential Blood Pressure Reduction and Secondary Stroke Prevention: A Meta-analysis and Meta-Regression

Chia-Yu Hsu et al. JAMA Neurol. .

Abstract

Importance: The degree to which more intensive blood pressure reduction is better than less intensive for secondary stroke prevention has not been delineated.

Objective: To perform a standard meta-analysis and a meta-regression of randomized clinical trials to evaluate the association of magnitude of differential blood pressure reduction and recurrent stroke in patients with stroke or transient ischemic attack (TIA).

Data sources: PubMed, Embase, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov were searched from January 1, 1980, to June 30, 2022.

Study selection: Randomized clinical trials that compared more intensive vs less intensive blood pressure lowering and recorded the outcome of recurrent stroke in patients with stroke or TIA.

Data extraction and synthesis: The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline was used for abstracting data and assessing data quality and validity. Risk ratio (RR) with 95% CI was used as a measure of the association of more intensive vs less intensive blood pressure lowering with primary and secondary outcomes. The univariate meta-regression analyses were conducted to evaluate a possible moderating effect of magnitude of differential systolic blood pressure (SBP) and diastolic blood pressure (DBP) reduction on the recurrent stroke and major cardiovascular events.

Main outcomes and measures: The primary outcome was recurrent stroke and the lead secondary outcome was major cardiovascular events.

Results: Ten randomized clinical trials comprising 40 710 patients (13 752 women [34%]; mean age, 65 years) with stroke or TIA were included for analysis. The mean duration of follow-up was 2.8 years (range, 1-4 years). Pooled results showed that more intensive treatment compared with less intensive was associated with a reduced risk of recurrent stroke in patients with stroke or TIA (absolute risk, 8.4% vs 10.1%; RR, 0.83; 95% CI, 0.78-0.88). Meta-regression showed that the magnitude of differential SBP and DBP reduction was associated with a lower risk of recurrent stroke in patients with stroke or TIA in a log-linear fashion (SBP: regression slope, -0.06; 95% CI, -0.08 to -0.03; DBP: regression slope, -0.17; 95% CI, -0.26 to -0.08). Similar results were found in the association between differential blood pressure lowering and major cardiovascular events.

Conclusions and relevance: More intensive blood pressure-lowering therapy might be associated with a reduced risk of recurrent stroke and major cardiovascular events. These results might support the use of more intensive blood pressure reduction for secondary prevention in patients with stroke or TIA.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Saver reported personal fees from Bayer, Johnson & Johnson, Biogen, Boehringer Ingelheim, and Roche outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Risk of Recurrent Stroke
Risk ratio with 95% CI of recurrent stroke with more intensive compared with less intensive blood pressure (BP)–lowering therapy in patients with stroke or transient ischemic attack (TIA). PROGRESS indicates Perindopril Protection Against Recurrent Stroke Study; SBP, systolic blood pressure.
Figure 2.
Figure 2.. Meta-Regression of Recurrent Stroke
Meta-regression of included trials to explore the association between magnitude of differential systolic blood pressure (SBP) reduction (A) and differential diastolic blood pressure (DBP) reduction (B) vs recurrent stroke rate. RR indicates risk ratio.
Figure 3.
Figure 3.. Meta-Regression of Major Cardiovascular Events
Meta-regression of included trials to explore the association between magnitude of (A) differential systolic blood pressure (SBP) reduction and (B) differential diastolic blood pressure (DBP) reduction vs major cardiovascular events. RR indicates risk ratio.
See this image and copyright information in PMC

References

    1. Hong KS, Yegiaian S, Lee M, Lee J, Saver JL. Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design. Circulation. 2011;123(19):2111-2119. doi: 10.1161/CIRCULATIONAHA.109.934786 - DOI - PMC - PubMed
    1. Yusuf S, Diener HC, Sacco RL, et al. ; PRoFESS Study Group . Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008;359(12):1225-1237. doi: 10.1056/NEJMoa0804593 - DOI - PMC - PubMed
    1. Kitagawa K, Yamamoto Y, Arima H, et al. ; Recurrent Stroke Prevention Clinical Outcome (RESPECT) Study Group . Effect of standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis. JAMA Neurol. 2019;76(11):1309-1318. doi: 10.1001/jamaneurol.2019.2167 - DOI - PMC - PubMed
    1. PROGRESS Collaborative Group . Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358(9287):1033-1041. doi: 10.1016/S0140-6736(01)06178-5 - DOI - PubMed
    1. Benavente OR, Coffey CS, Conwit R, et al. ; SPS3 Study Group . Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013;382(9891):507-515. doi: 10.1016/S0140-6736(13)60852-1 - DOI - PMC - PubMed

Publication types